Invention Application
- Patent Title: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
Application No.: US14038304Application Date: 2013-09-26
-
Publication No.: US20140094471A1Publication Date: 2014-04-03
- Inventor: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert A. Mantei , Todd M. Hansen
- Applicant: AbbVie Inc. , The Walter and Eliza Hall Institute of Medical Research , Genentech, Inc.
- Applicant Address: US IL North Chicago AU Parkville US CA South San Francisco
- Assignee: AbbVie Inc.,The Walter and Eliza Hall Institute of Medical Research,Genentech, Inc.
- Current Assignee: AbbVie Inc.,The Walter and Eliza Hall Institute of Medical Research,Genentech, Inc.
- Current Assignee Address: US IL North Chicago AU Parkville US CA South San Francisco
- Main IPC: C07D471/04
- IPC: C07D471/04 ; C07D403/12 ; C07D209/82
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US09174982B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Public/Granted day:2015-11-03
Information query
